# FDA Inspection 1049579 - Biomat USA Inc - April 13, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/2b46e65b-769c-4941-942b-446e3719ed72
Source feed: FDA_Inspections

> FDA Inspection 1049579 for Biomat USA Inc on April 13, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1049579
- Company Name: Biomat USA Inc
- Inspection Date: 2018-04-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 938527 - 2015-08-13](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/7da8fe47-7bc9-4d0b-8b3e-6a4e69280b9d)
- [FDA Inspection 812632 - 2012-12-18](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/92feaee1-29af-4125-9e0b-65edc6a35b43)
- [FDA Inspection 615009 - 2009-09-25](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/43672942-5e17-496b-a16d-6ca5d964c15c)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/ca822741-1ca8-48d2-a64d-25c3e3733dde

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d